Logo image of CAUD

COLLECTIVE AUDIENCE INC (CAUD) Stock Fundamental Analysis

NASDAQ:CAUD - Nasdaq - US1939391058 - Common Stock - Currency: USD

0.2061  -0.23 (-52.29%)

After market: 0.2152 +0.01 (+4.42%)

Fundamental Rating

0

CAUD gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 93 industry peers in the Media industry. CAUD may be in some trouble as it scores bad on both profitability and health. CAUD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CAUD has reported negative net income.
CAUD had a negative operating cash flow in the past year.
CAUD Yearly Net Income VS EBIT VS OCF VS FCFCAUD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -2M -4M -6M

1.2 Ratios

CAUD has a worse Return On Assets (-20.51%) than 86.02% of its industry peers.
Industry RankSector Rank
ROA -20.51%
ROE N/A
ROIC N/A
ROA(3y)-19.3%
ROA(5y)N/A
ROE(3y)-65.61%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CAUD Yearly ROA, ROE, ROICCAUD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

CAUD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CAUD Yearly Profit, Operating, Gross MarginsCAUD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 -10 -20 -30 -40 -50

More info and screens

0

2. Health

2.1 Basic Checks

CAUD has more shares outstanding than it did 1 year ago.
CAUD has a worse debt/assets ratio than last year.
CAUD Yearly Shares OutstandingCAUD Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M 10M
CAUD Yearly Total Debt VS Total AssetsCAUD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

CAUD has an Altman-Z score of -2.41. This is a bad value and indicates that CAUD is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CAUD (-2.41) is worse than 80.65% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.41
ROIC/WACCN/A
WACCN/A
CAUD Yearly LT Debt VS Equity VS FCFCAUD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 10M 20M 30M 40M 50M

2.3 Liquidity

CAUD has a Current Ratio of 0.23. This is a bad value and indicates that CAUD is not financially healthy enough and could expect problems in meeting its short term obligations.
CAUD's Current ratio of 0.23 is on the low side compared to the rest of the industry. CAUD is outperformed by 98.92% of its industry peers.
CAUD has a Quick Ratio of 0.23. This is a bad value and indicates that CAUD is not financially healthy enough and could expect problems in meeting its short term obligations.
CAUD's Quick ratio of 0.23 is on the low side compared to the rest of the industry. CAUD is outperformed by 98.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23
CAUD Yearly Current Assets VS Current LiabilitesCAUD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CAUD have decreased strongly by -64.62% in the last year.
EPS 1Y (TTM)-64.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-83.38%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CAUD Yearly Revenue VS EstimatesCAUD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2M 4M 6M 8M 10M
CAUD Yearly EPS VS EstimatesCAUD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CAUD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CAUD Price Earnings VS Forward Price EarningsCAUD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAUD Per share dataCAUD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CAUD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COLLECTIVE AUDIENCE INC

NASDAQ:CAUD (8/15/2024, 8:00:02 PM)

After market: 0.2152 +0.01 (+4.42%)

0.2061

-0.23 (-52.29%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-14 2024-08-14/amc
Earnings (Next)11-12 2024-11-12
Inst Owners0.19%
Inst Owner Change204.32%
Ins Owners22.72%
Ins Owner Change2.07%
Market Cap3.51M
AnalystsN/A
Price TargetN/A
Short Float %0.31%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-19.3%
ROA(5y)N/A
ROE(3y)-65.61%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z -2.41
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-83.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y98%
OCF growth 3YN/A
OCF growth 5YN/A